Fasken advised Theratechnologies in this transaction. Theratechnologies Inc. (Nasdaq: THTX; TSX: TH) completed a cross-border public offering of 12,500,000 common shares of the company at US$1.00…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
